Opal Wealth Advisors
CVS icon

Opal Wealth Advisors’s CVS Health CVS Stock Holding History

Opal Wealth Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$229K Sell
2,670
-709
-21% -$69.4K 0.05% 189
2026
Q2 		$350K Buy
3,379
+1,745
+107% +$156K 0.08% 145
2026
Q1 		$117K Buy
+1,634
New +$126K 0.03% 260
2025
Q3 		– Sell
-1,382
Closed -$95.3K – 276
2025
Q2 		$95.3K Sell
1,382
-316
-19% -$20.7K 0.03% 277
2025
Q1 		$115K Buy
+1,698
New +$102K 0.04% 255
2024
Q4 		– Sell
-4,442
Closed -$279K – 195
2024
Q3 		$279K Sell
4,442
-769
-15% -$44.9K 0.09% 136
2024
Q2 		$308K Sell
5,211
-121
-2% -$7.57K 0.1% 123
2024
Q1 		$425K Buy
5,332
+14
+0.3% +$1.07K 0.14% 93
2023
Q4 		$420K Sell
5,318
-518
-9% -$36.9K 0.17% 92
2023
Q3 		$407K Buy
5,836
+764
+15% +$54.1K 0.24% 67
2023
Q2 		$351K Sell
5,072
-561
-10% -$39.9K 0.17% 79
2023
Q1 		$419K Buy
5,633
+195
+4% +$16.4K 0.24% 49
2022
Q4 		$507K Buy
5,438
+161
+3% +$15.5K 0.28% 52
2022
Q3 		$503K Sell
5,277
-119
-2% -$11.8K 0.37% 42
2022
Q2 		$500K Buy
5,396
+52
+1% +$5.08K 0.33% 43
2022
Q1 		$541K Sell
5,344
-336
-6% -$35.3K 0.47% 31
2021
Q4 		$586K Buy
5,680
+2,069
+57% +$191K 0.37% 46
2021
Q3 		$306K Sell
3,611
-1,924
-35% -$161K 0.29% 48
2021
Q2 		$462K Buy
5,535
+1,744
+46% +$143K 0.43% 33
2021
Q1 		$285K Buy
+3,791
New +$276K 0.31% 46

Other funds holding CVS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Opal Wealth Advisors's CVS Position: Q3 2026 in Review

Opal Wealth Advisors reduced its CVS Health (CVS) stake by 21% in Q3 2026, selling an estimated $69.4K and leaving 2,670 shares worth $229K. The position accounts for 0.05% of the portfolio, ranked #189.

Opal Wealth Advisors first reported a position in CVS in Q1 2021 and has held it in 20 quarters since. The position peaked at $586K in Q4 2021. 1,129 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Opal Wealth Advisors held 2,670 shares of CVS Health worth $229K as of Q3 2026.
  • Opal Wealth Advisors sold 709 CVS Health shares in Q3 2026, an estimated $69.4K.
  • CVS Health made up 0.05% of Opal Wealth Advisors's portfolio in Q3 2026, its #189 holding.
  • Opal Wealth Advisors first reported a position in CVS Health in Q1 2021 and has held it in 20 quarters since.
  • Opal Wealth Advisors's CVS Health position peaked at $586K in Q4 2021.
  • 1,129 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Opal Wealth Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.